Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

We have investigated the molecular basis of biological differences observed among cell line-adapted isolates of the human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) and the simian immunodeficiency virus (SIV) in response to receptor binding by using a soluble form of CD4 (sCD4) as a receptor mimic. We find that sCD4 binds to the envelope glycoproteins of all of the HIV-1 isolates tested with affinities within a threefold range, whereas those of the HIV-2 and SIV isolates have relative affinities for sCD4 two- to eightfold lower than those of HIV-1. Treatment of infected cells with sCD4 induced the dissociation of gp120 from gp41 and increased the exposure of a cryptic gp41 epitope on all of the HIV-1 isolates. By contrast, neither dissociation of the outer envelope glycoprotein nor increased exposure of the transmembrane glycoprotein was observed when sCD4 bound to HIV-2- or SIV-infected cells. Moreover, immunoprecipitation with sCD4 resulted in the coprecipitation of the surface and transmembrane glycoproteins from virions of the HIV-2 and SIV isolates, whereas the surface envelope glycoprotein alone was precipitated from HIV-1. However, treatment of HIV-1-, HIV-2-, and SIV-infected cells with sCD4 did result in an increase in exposure of their V2 and V3 loops, as detected by enhanced antibody reactivity. This demonstrates that receptor binding to the outer envelope glycoprotein induces certain conformational changes which are common to all of these viruses and others which are restricted to cell line-passaged isolates of HIV-1.

[1]  J. Bentz,et al.  Membrane Fusion Induced by the HIV env Glycoprotein: Purification of CD4 for Reconstitution Studies , 1995 .

[2]  J. Moore,et al.  Adaptation of two primary human immunodeficiency virus type 1 isolates to growth in transformed T cell lines correlates with alterations in the responses of their envelope glycoproteins to soluble CD4. , 1993, AIDS research and human retroviruses.

[3]  J. Allan,et al.  Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activation. , 1992, AIDS research and human retroviruses.

[4]  L. Lopalco,et al.  Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? , 1992, AIDS research and human retroviruses.

[5]  J. Sodroski,et al.  Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events , 1992, Journal of virology.

[6]  R. Weiss,et al.  Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4 , 1992, Journal of virology.

[7]  L. Montagnier,et al.  Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans. , 1992, AIDS research and human retroviruses.

[8]  D. Dimitrov,et al.  Correlation between kinetics of soluble CD4 interactions with HIV‐1-Env‐expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS , 1992, AIDS.

[9]  M. Mulligan,et al.  Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex. , 1992, Virology.

[10]  J. Moore,et al.  Kinetics of the HIV-CD4 interactions and virus-cell fusion. , 1992, AIDS.

[11]  R. Schooley,et al.  Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Dimitrov,et al.  Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein , 1992, Journal of virology.

[13]  J. Moore,et al.  Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates , 1992, Journal of virology.

[14]  Q. Sattentau.  CD4 activation of HIV fusion. , 1992, International journal of cell cloning.

[15]  D. Ho,et al.  Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Lifson,et al.  Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Zolla-Pazner,et al.  Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies , 1991, Journal of virology.

[18]  J. Sodroski,et al.  Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity , 1991, Journal of virology.

[19]  J. Hoxie,et al.  Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4 , 1991, Journal of virology.

[20]  D. Ho,et al.  Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Q. Sattentau,et al.  Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding , 1991, The Journal of experimental medicine.

[22]  H. Gayle,et al.  Oligomeric nature of transmembrane glycoproteins of HIV-2: procedures for their efficient dissociation and preparation of Western blots for diagnosis. , 1991, AIDS.

[23]  L. Gritz,et al.  Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. , 1991, AIDS.

[24]  J. Hoxie,et al.  Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins. , 1991, AIDS research and human retroviruses.

[25]  J. Allan.  Receptor-mediated activation of immunodeficiency viruses in viral fusion. , 1991, Science.

[26]  R. Weiss,et al.  Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus , 1991, Virology.

[27]  H. Ellens,et al.  Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Q. Sattentau,et al.  Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4 , 1991, Journal of virology.

[29]  J. Moore,et al.  Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization , 1991, Journal of virology.

[30]  J. Culp,et al.  Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Moore,et al.  Binding of recombinant HIV-1 and HIV-2 SU glycoproteins to sCD4. , 1991, Journal of acquired immune deficiency syndromes.

[32]  R. Kurth,et al.  Soluble CD4 enhances simian immunodeficiency virus SIVagm infection , 1990, Journal of virology.

[33]  Q. Sattentau,et al.  Dissociation of gp120 from HIV-1 virions induced by soluble CD4. , 1990, Science.

[34]  J. Levy,et al.  Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles , 1990, Journal of virology.

[35]  R. Redfield,et al.  Differences in the interaction of HIV-1 and HIV-2 with CD4. , 1990, Journal of acquired immune deficiency syndromes.

[36]  Q. Sattentau,et al.  Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding , 1990, The Journal of experimental medicine.

[37]  H. Ellens,et al.  Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1. , 1990, AIDS research and human retroviruses.

[38]  J. Groopman,et al.  CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells , 1990, Journal of virology.

[39]  J. Spouge,et al.  HIV requires multiple gp120 molecules for CD4-mediated infection , 1990, Nature.

[40]  P. Earl,et al.  Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus env proteins possess a functionally conserved assembly domain , 1990, Journal of virology.

[41]  J. Moore.  Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4. , 1990, AIDS.

[42]  J. Allan,et al.  Enhancement of SIV infection with soluble receptor molecules. , 1990, Science.

[43]  L. Montagnier,et al.  Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers , 1990, Journal of virology.

[44]  P. Earl,et al.  Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Skehel,et al.  Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV. , 1989, Virology.

[46]  S. Zolla-Pazner,et al.  Generation of human monoclonal antibodies to human immunodeficiency virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Dalgleish,et al.  Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells , 1989, Nature.

[48]  A. J. Garrett,et al.  Electron microscopy of human immunodeficiency virus. , 1988, The Journal of general virology.

[49]  C. Goldsmith,et al.  Ultrastructure of human immunodeficiency virus type 2. , 1988, The Journal of general virology.

[50]  Q. Sattentau,et al.  The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. , 1988, AIDS.

[51]  R. Axel,et al.  soluble form of CD4 (T4) protein inhibits AIDS virus infection , 1988, Nature.

[52]  I. Wilson,et al.  Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin , 1987, The Journal of cell biology.

[53]  G. Nakamura,et al.  Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.

[54]  J K Nicholson,et al.  Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. , 1986, Science.

[55]  I. Wilson,et al.  Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. , 1982, Proceedings of the National Academy of Sciences of the United States of America.